JPRN-jRCT2080221035未知3 期
ong-Term Safety and Efficacy of FYX-051 in Patients with Hyperuricemia (with or without Gout)
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Patients with hyperuricemia with the following serum urate level:
- •- Serum urate level of >= 7.0mg/dL in patients with history of gout, or
- •- Serum urate level of >= 8.0mg/dL in patients with renal stones, hypertension, hyperlipidemia or diabetes, or
- •- Serum urate level of >= 9.0mg/d
排除标准
- •Patients with gouty arthritis within two weeks before start of study treatment
- •Patients with secondary hyperuricemia
- •Patients with, or a history of, clinically significant cardiac, hematologic and hepatic disease
研究者
相似试验
未知
3 期
ong-Term Safety and Efficacy of FYX-051 in Patients with Hyperuricemia (with or without Gout)JPRN-jRCT2080221050Fuji Yakuhin Co., Ltd.
未知
2 期
Clinical pharmacology study of FYX-051 for subjects with renal insufficiencySubjects with renal insufficiencyJPRN-jRCT2080221510Fuji Yakuhin Co., Ltd.
未知
3 期
Efficacy and safety of FYX-051 compared with allopurinol in Patients with Hyperuricemia (with or without Gout)Hyperuricemia and GoutJPRN-jRCT2080221074SANWA KAGAKU KENKYUSHO Co., Ltd.
未知
2 期
Exploratory study of FYX-051 in Patients with Hyperuricemia (with or without Gout)Hyperuricemia and GoutJPRN-jRCT2080221278Fuji Yakuhin Co., Ltd.
未知
2 期
Exploratory study 2 of FYX-051 in Patients with Hyperuricemia (with or without Gout)Hyperuricemia and GoutJPRN-jRCT2080221279Fuji Yakuhin Co., Ltd.